Crystal structures of ryanodine receptor SPRY1 and tandem-repeat domains reveal a critical FKBP12 binding determinant

Nature Communications

Volumn 6, Issue , 2015, Pages

  Yuchi, Zhiguang ^a   Yuen, Siobhan M Wong King ^a   Lau, Kelvin ^a,d   Underhill, Ainsley Q ^a   Cornea, Razvan L ^b   Fessenden, James D ^c   Van Petegem, Filip ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; RYANODINE RECEPTOR; RYANODINE RECEPTOR SPRY1; UNCLASSIFIED DRUG;

CALCIUM; COMPUTER SIMULATION; CRYSTAL STRUCTURE; HOMOLOGY; HYDROPHOBICITY; MEMBRANE; MOLECULAR ANALYSIS; MUTAGENICITY; MUTATION; RECONSTRUCTION;

ARTICLE; BINDING ASSAY; CRYSTAL STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MUTAGENESIS; NONHUMAN; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; TANDEM REPEAT; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CRYSTALLIZATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTATION; PROTEIN TERTIARY STRUCTURE; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; CRYSTALLIZATION; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY; RABBITS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACROLIMUS BINDING PROTEIN 1A;

EID: 84938816958     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8947     Document Type: Article

References (61)

1. Van Petegem, F. Ryanodine receptors: structure and function. J. Biol. Chem. 287, 31624-31632 (2012).
2. Van Petegem, F. Ryanodine Receptors: Allosteric Ion Channel Giants. J. Mol. Biol. 427, 31-53 (2015).
3. Seo, M. D., Enomoto, M., Ishiyama, N., Stathopulos, P. B. & Ikura, M. Structural insights into endoplasmic reticulum stored calcium regulation by inositol 1,4,5-trisphosphate and ryanodine receptors. Biochim. Biophys. Acta. doi: 10.1016/j.bbamcr.2014.11.023 (2014).
4. Lobo, P. A. & Van Petegem, F. Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations. Structure 17, 1505-1514 (2009).
5. Tung, C. C., Lobo, P. A., Kimlicka, L. & Van Petegem, F. The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature 468, 585-588 (2010).
6. Lobo, P. A., Kimlicka, L., Tung, C. C. & Van Petegem, F. The deletion of exon 3 in the cardiac ryanodine receptor is rescued by beta strand switching. Structure 19, 790-798 (2011).
7. Kimlicka, L., Lau, K., Tung, C. C. & Van Petegem, F. Disease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interface. Nat. Commun. 4, 1506 (2013).
8. Kimlicka, L. et al. The cardiac ryanodine receptor N-terminal region contains an anion binding site that is targeted by disease mutations. Structure 21, 1440-1449 (2013).
9. Amador, F. J. et al. Type 2 ryanodine receptor domain A contains a unique and dynamic alpha-helix that transitions to a beta-strand in a mutant linked with a heritable cardiomyopathy. J. Mol. Biol. 425, 4034-4046 (2013).
10. Borko, L. et al. Structural insights into the human RyR2 N-terminal region involved in cardiac arrhythmias. Acta Crystallogr. D Biol. Crystallogr. 70, 2897-2912 (2014).
11. Lau, K. & Van Petegem, F. Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. Nat. Commun. 5, 5397 (2014).
12. Yuchi, Z., Lau, K. & Van Petegem, F. Disease mutations in the ryanodine receptor central region: crystal structures of a phosphorylation hot spot domain. Structure 20, 1201-1211 (2012).
13. Sharma, P. et al. Structural determination of the phosphorylation domain of the ryanodine receptor. FEBS J. 279, 3952-3964 (2012).
14. Kimlicka, L. & Van Petegem, F. The structural biology of ryanodine receptors. Sci. China Life Sci. 54, 712-724 (2011).
15. Efremov, R. G., Leitner, A., Aebersold, R. & Raunser, S. Architecture and conformational switch mechanism of the ryanodine receptor. Nature 517, 39-43 (2015).
16. Zalk, R. et al. Structure of a mammalian ryanodine receptor. Nature 517, 44-49 (2015).
17. Yan, Z. et al. Structureof the rabbit ryanodine receptor RyR1 at near-atomic resolution. Nature 517, 50-55 (2015).
18. Wang, D., Li, Z., Messing, E. M. & Wu, G. Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM. J. Biol. Chem. 277, 36216-36222 (2002).
19. Ponting, C., Schultz, J. & Bork, P. SPRY domains in ryanodine receptors (Ca(2+)-release channels. Trends. Biochem. Sci. 22, 193-194 (1997).
20. Brillantes, A. B. et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 77, 513-523 (1994).
21. Marx, S. O. et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365-376 (2000).
22. Fauconnier, J. et al. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA 107, 1559-1564 (2010).
23. Andersson, D. C. et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 14, 196-207 (2011).
24. Andersson, D. C. & Marks, A. R. Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle. Drug. Discov. Today Dis. Mech. 7, e151-e157 (2010).
25. Yano, M. et al. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107, 477-484 (2003).
26. Wehrens, X. H. et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304, 292-296 (2004).
27. Samso, M., Shen, X. & Allen, P. D. Structural characterization of the RyR1-FKBP12 interaction. J. Mol. Biol. 356, 917-927 (2006).
28. Sharma, M. R., Jeyakumar, L. H., Fleischer, S. & Wagenknecht, T. Threedimensional visualization of FKBP12.6 binding to an open conformation of cardiac ryanodine receptor. Biophys. J. 90, 164-172 (2006).
29. Samso, M., Feng, W., Pessah, I. N. & Allen, P. D. Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol. 7, e85 (2009).
30. Cornea, R. L., Nitu, F. R., Samso, M., Thomas, D. D. & Fruen, B. R. Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer. J. Biol. Chem. 285, 19219-19226 (2010).
31. Gaburjakova, M. et al. FKBP12 binding modulates ryanodine receptor channel gating. J. Biol. Chem. 276, 16931-16935 (2001).
32. Masumiya, H., Wang, R., Zhang, J., Xiao, B. & Chen, S. R. Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor). J. Biol. Chem. 278, 3786-3792 (2003).
33. Girgenrath, T. et al. N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins. J. Biol. Chem. 288, 16073-16084 (2013).
34. Zissimopoulos, S. & Lai, F. A. Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain. J. Biol. Chem. 280, 5475-5485 (2005).
35. Garzon, J. I., Kovacs, J., Abagyan, R. & Chacon, P. ADP-EM: fast exhaustive multi-resolution docking for high-throughput coverage. Bioinformatics. 23, 427-433 (2007).
36. Wriggers, W. & Birmanns, S. Using situs for flexible and rigid-body fitting of multiresolution single-molecule data. J. Struct. Biol. 133, 193-202 (2001).
37. Levano, S. et al. Increasing the number of diagnostic mutations in malignant hyperthermia. Hum. Mutat. 30, 590-598 (2009).
38. Klein, A. et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum. Mutat. 33, 981-988 (2012).
39. Ferguson, D. G., Schwartz, H. W. & Franzini-Armstrong, C. Subunit structure of junctional feet in triads of skeletal muscle: a freeze-drying, rotary-shadowing study. J. Cell Biol. 99, 1735-1742 (1984).
40. Franzini-Armstrong, C., Protasi, F. & Ramesh, V. Shape, size, and distribution of Ca(2+) release units and couplons in skeletal and cardiac muscles. Biophys. J. 77, 1528-1539 (1999).
41. Yin, C. C., Han, H., Wei, R. & Lai, F. A. Two-dimensional crystallization of the ryanodine receptor Ca2+ release channel on lipid membranes. J. Struct. Biol. 149, 219-224 (2005).
42. Zhou, H. et al. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul. Disord. 20, 166-173 (2010).
43. Bharucha-Goebel, D. X. et al. Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum. Neurology 80, 1584-1589 (2013).
44. Seo, M. D. et al. Structural and functional conservation of key domains in InsP(3) and ryanodine receptors. Nature 483, 108-112 (2012).
45. Zhong, X. et al. Conformational dynamics inside amino-terminal disease hotspot of ryanodine receptor. Structure 21, 2051-2060 (2013).
46. Ludtke, S. J. et al. Flexible architecture of IP3R1 by Cryo-EM. Structure 19, 1192-1199 (2011).
47. Wang, R. et al. Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor. J. Biol. Chem. 286, 12202-12212 (2011).
48. Studier, F. W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41, 207-234 (2005).
49. Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132 (2010).
50. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).
51. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501 (2010).
52. Pettersen, E. F. et al. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
53. Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815 (1993).
54. Phillips, J. C. et al. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781-1802 (2005).
55. Trabuco, L. G., Villa, E., Mitra, K., Frank, J. & Schulten, K. Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. Structure 16, 673-683 (2008).
56. Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 27-38 (1996).
57. Nettleship, J. E., Brown, J., Groves, M. R. & Geerlof, A. Methods for protein characterization by mass spectrometry, thermal shift (ThermoFluor) assay, and multiangle or static light scattering. Methods Mol. Biol. 426, 299-318 (2008).
58. Mahalingam, M. et al. Structural mapping of divergent regions in the type 1 ryanodine receptor using fluorescence resonance energy transfer. Structure 22, 1322-1332 (2014).
59. Fessenden, J. D. Forster resonance energy transfer measurements of ryanodine receptor type 1 structure using a novel site-specific labeling method. PLoS ONE 4, e7338 (2009).
60. Cornea, R. L. et al. FRET-based mapping of calmodulin bound to the RyR1 Ca2+ release channel. Proc. Natl Acad. Sci. USA 106, 6128-6133 (2009).
61. Svensson, B. et al. FRET-based trilateration of probes bound within functional ryanodine receptors. Biophys. J. 107, 2037-2048 (2014).